Quest Laboratories share news and announcements

NSE: QUESTLABPharmaceuticals & Biotechnology

₹82.00₹5.40 (6.18%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹87.40.

52-week range of traded prices to 23 Oct 2026

₹68.60Low, 21 Sep 2026₹152.60High, 30 Apr 2026

Market cap: ₹134 Cr
P/E: No recent results
P/B: No recent results
Dividend yield: Nonein the last 12 months
Volume, NSE: 12,00090.0% delivered

Quest Laboratories disputes and clarifications

6 filed, newest first.

Feb 2026
- 9 Feb · Legal
  Exchange had sought clarification from Quest Laboratories Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1.Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. (opens in a new tab)
Jan 2026
- 13 Jan · Legal
  Exchange has sought clarification from Quest Laboratories Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited. (opens in a new tab)
Aug 2025
- 18 Aug · Legal
  Exchange had sought clarification from Quest Laboratories Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. (opens in a new tab)
Jun 2025
- 24 Jun · Legal
  Exchange has sought clarification from Quest Laboratories Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited. (opens in a new tab)
Aug 2024
- 26 Aug · Legal
  Exchange had sought clarification from Quest Laboratories Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is enclosed. (opens in a new tab)
Jun 2024
- 28 Jun · Legal
  Exchange has sought clarification from Quest Laboratories Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited. (opens in a new tab)

Quest Laboratories disputes and clarifications

Feb 2026

Jan 2026

Aug 2025

Jun 2025

Aug 2024

Jun 2024